Given the effects of ERα on integrin β4, we hypothesized that estrogen activates the ERα-ΔNp63-integrin β4 axis in ERα-positive MCF-7 breast cancer cells and induces cell viability and cell motility. The gene discussed is ESR1; the disease is breast carcinoma.